I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Evaluating newly approved drugs for multidrug-resistant tub..:
Guglielmetti, L
;
Ardizzoni, E
;
Atger, M
...
info:eu-repo/semantics/altIdentifier/doi/10.1186/s13063-021-05491-3. , 2021
Link:
https://hal.sorbonne-universite.fr/hal-03368536
RT Journal T1
Evaluating newly approved drugs for multidrug-resistant tuberculosis (endTB): study protocol for an adaptive, multi-country randomized controlled trial
UL https://suche.suub.uni-bremen.de/peid=base-ftsorbonneuniv:oai:HAL:hal-03368536v1&Exemplar=1&LAN=DE A1 Guglielmetti, L A1 Ardizzoni, E A1 Atger, M A1 Baudin, Emmanuel A1 Berikova, E A1 Bonnet, Maryline A1 Chang, E A1 Cloez, S A1 Coit, J., M A1 Cox, V A1 de Jong, B., C A1 Delifer, C A1 Do, J., M A1 Tozzi, D. dos Santos A1 Ducher, V A1 Ferlazzo, G A1 Gouillou, M A1 Khan, A A1 Khan, U A1 Lachenal, N A1 Lahood, A., N A1 Lecca, L A1 Mazmanian, M A1 Mcilleron, H A1 Moschioni, M A1 O'Brien, K A1 Okunbor, O A1 Oyewusi, L A1 Panda, S A1 Patil, S., B A1 Phillips, P., P. J A1 Pichon, L A1 Rupasinghe, P A1 Rich, M., L A1 Saluhuddin, N A1 Seung, K., J A1 Tamirat, M A1 Trippa, L A1 Cellamare, M A1 Velásquez, G., E A1 Wasserman, S A1 Zimetbaum, P., J A1 Varaine, F A1 Mitnick, C., D PB HAL CCSD; BioMed Central YR 2021 K1 Bayesian adaptive randomization K1 Bedaquiline K1 Clofazimine K1 Delamanid K1 Fluoroquinolone K1 Linezolid K1 MDR-TB K1 Non-inferiority K1 Pyrazinamide K1 Rifampin-resistant tuberculosis K1 Treatment shortening K1 MESH: Antitubercular Agents K1 MESH: Bayes Theorem K1 MESH: Humans K1 MESH: Pharmaceutical Preparations K1 MESH: Randomized Controlled Trials as Topic K1 MESH: Rifampin K1 MESH: Tuberculosis K1 Multidrug-Resistant K1 [SDV.SP]Life Sciences [q-bio]/Pharmaceutical sciences JF info:eu-repo/semantics/altIdentifier/doi/10.1186/s13063-021-05491-3 LK http://dx.doi.org/https://hal.sorbonne-universite.fr/hal-03368536 DO https://hal.sorbonne-universite.fr/hal-03368536 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)